COVID-19

Rapid evolution and host immunity drive the rise and fall of antibiotic resistance during...

Antibiotic resistance poses a serious threat to human health. Resistant infections now cause more than 750,000 deaths per year and are predicted to increase to 10 million deaths per year by 2050.

Accelerating Creativity and Excellence (ACE) Grant 2020

The use of rehabilitation robot is becoming increasingly popular as an alternative form of treatment in recent years and the COVID-19...

Immune cell regulator discovery could lead to treatments for arthritis and severe COVID

The discovery of new regulator-affecting immune cells could lead to novel treatments to reduce inflammation in diseases, including arthritis and severe COVID-19.

Antibody therapies against Covid-19 for most vulnerable patients work, new analysis finds

The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective, a new study has found.

3Q: Looking back at MIT’s fall semester Covid-19 testing

Suzanne Blake of MIT Emergency Management analyzes the results from the program, which administered more than 250,000 tests last semester.

Coronavirus antibodies last at least three months after infection, University of Toronto study finds

Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a study published in Science Immunology.

Growing inequality in job market risks widening disadvantage gap between children

Parents who were already disadvantaged before the pandemic were more likely to have suffered a salary cut or unemployment during the crisis

Online farmers’ markets valuable when crisis events like COVID occur

AI-powered symptom checkers can potentially reduce the number of people going to in-person clinics during the pandemic, but first, researchers say, people need to know they exist.